FDA Investigator M Patriciaurphy Murphy
M Patriciaurphy Murphy has inspections in 16 countries as of 25 Oct 2023. M Patriciaurphy Murphy has collaborated with a combined 3287 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
407
Last Inspection Date:
25 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Poland,
Denmark,
Canada,
United Kingdom of Great Britain and Northern Ireland,
Belgium,
Serbia,
Japan,
Germany,
Marshall Islands,
Austria,
India,
Jamaica,
Czechia,
Netherlands
Co-Investigator(s):
Abby E Pelletier,
Abraham M Maekele,
Abthony C Warchut,
Alan R Condon,
Alfred P Pistorio,
Alice C Silva,
Allison E Sincek,
Alysia M Salonia,
Amanda E Lewin, PhD,
Amy C Jordan,
Andrew M Barlow,
Andrew Saunders,
Angela Mock,
Angela Shepas,
Anita R Michael,
Anthony C Warchut,
Anthony N Onianwa,
Anthony W Thomas,
Arindam Dasgupta, PhD,
Barbara A Gullick,
Betsy C Galliher,
Byungja E Marciante,
Camerson E Moore,
Cara M Minelli,
Carol G Rochester,
Carr,
Christine M Smith,
Christopher B May,
Christopher C Wilcox,
Christopher Janik,
Chunsheng Cai, PhD,
Constance Desimone,
Courtney N Long,
Cynthia F Kleppinger, MD,
Cynthia L Rakestraw,
Darin S Wiegers,
Daryl A Dewoskin,
Dawn C Olenjack,
Dawn M Braswell,
Deborah A Greco,
Diane C Thibodeau,
Diane Kelley,
Diane M Biron,
Dien N Nguyen,
Dominic R Frasca,
Don A Leeseberg,
Douglas Florentino,
Dr. Sriram Subramaniam, PhD,
Edmund F Mrak, Jr,
Eduardo L Rodriguez,
Edward J Janik,
Ellen P Madigan,
Emmanuel A Dimaano, Jr,
Erich P Garger,
Francis A Guidry,
Frank J Koch,
Gabriel E Muniz,
Gabrielle J Swain,
Gale E Ryan,
Gary J Hagan,
George T Allen, Jr,
Gerald T O'connor,
Hang N Guo,
Hasan A Irier, PhD,
Iram R Hassan, PhD,
Ivis L Negron,
Ivis Lnegron Torres,
Jaclyn N Munsch,
Jacqueline M Bowling,
James M Kewley,
James R Fleckenstein,
James R Wormuth,
Jamie S Mathews,
Janete F Guardia,
Jay M Patria,
Jeanne F Broderick,
Jeffrey A Sincek,
Jeffrey J Thibodeau,
Jocelyn T Ramos,
John A Hollings,
John D Mays,
John J Thibodeau,
John L Zaccone,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
Jorge E Martinez,
Jose A Torres,
Jose Acruz Gonzalez,
Joseph J Vannelli,
Joshua L Gibbs,
Joyce A Kellett,
Kara A Scheibner, PhD,
Karen M Cooper,
Karen Mcnabb Noon,
Karen R Smallwood,
Kent A Conforti,
Khin Mang U, MD,
Kimberly A Benson,
Kristina J Donohue,
Laurie B Frazier,
LCDR Debra Emerson,
LCDR Matthew J Morrison,
Lequita M Mayhew,
Linda L Green,
Lori A Holmquist,
Margaret A Foster,
Margaret M Sands,
Maricelys Mercado,
Mark E Farrell,
Mark R Mcclain,
Martin J Guardia,
Mary P Murphy,
Matthew C Watson,
Maya M Davis,
Melkamu Getie Kebtie, PhD,
Miah Jung,
Michael C Ireland,
Michael E Cimaglio,
Michael G Mayfield,
Michael J Kuchta,
Michael J Leal,
Michael P Anthony,
Michael Serrano,
Michelle Hawkins,
Michelle M Noe,
Michelle M Noe Varga,
Michelle Rfrazier Jessen, PhD,
Miguel A Martinez,
Minerva Rogers,
Mohsen Rajabi Abhari, FDA,
Monica E Caphart,
Mpris Inspector,
Murray Kurzman,
Nabil Nakhoul,
Nasser Yazdani,
Nealie C Newberger,
Nichole B Murphy,
Nina Yang,
Normica G Facey,
Osama A Khatib,
Paraluman S Leonin,
Paul A Licata,
Paul E Stein,
Paul L Yeh,
Paul P Geraci,
Paula M Laplant,
Peter R Lenahan,
Rachel T Evans,
Rapti D Madurawe,
Rebecca B Welch,
Richard M Fejka,
Richard W Berning,
Robert E Davis,
Robert G Antonsen, Jr,
Robert M Barbosa,
Robert Mo Brien,
Rterry Bolen,
Samuel L Murray,
Sarah L Clark,
Scotty L Hargrave,
Sharon K Gershon,
Sheri L Stephenson,
Sherri N Rohlf, MD,
Sherry M Nisson,
Simone E Pitts,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Stephen C Smith,
Stephen R Souza,
Sunita Pandey,
Susan D Yuscius,
Susanne M Richardson, MSc RAC ELS,
Suzie L Kent,
Tania E Vizcaino,
Terri L Jones,
Thomas D Clarida,
Thomas W Garvin,
Todd D Alspach,
Toni S Sturgis,
Traci C Kelm,
Tyanna N Hadley,
Victoria M Daddeo,
William K Dagley
M Patriciaurphy Murphy's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more